# Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - Inspection Records

Source: https://www.globalkeysolutions.net/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2

> Inspection records and compliance data for Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany in Whippany, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
- FEI Number: 2211084
- City: Whippany
- State: New Jersey
- Country Name: United States
- Address Line 1: 30 N Jefferson Rd
- Zip Code: 07981
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/29257cf4-a977-4a40-b47c-8c6427a29fb0) — source: FDA, date: December 8, 2025
- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/ff5fde2e-4f0e-44b5-9fd6-ece34ceb3753) — source: FDA, date: December 8, 2025
- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/9af496ca-9605-43b9-b726-ec5a90c149a0) — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2025
- [FDA Inspection 1297650 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2025-12-08](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/f9f091ad-021c-420a-97b8-ef23a38ac54f) — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2025
- [483 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2023-02-17](https://www.globalkeysolutions.net/records/483/halo-pharmaceutical-inc-dba-cambrex-whippany/85c16a13-185e-4160-8506-5e5d9a880e64) — source: FDA, date: February 17, 2023
- [FDA Inspection 1197680 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2023-02-17](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/977b66ca-6f39-4a4d-b230-c50aeda40300) — classification: No Action Indicated (NAI), source: FDA, date: February 17, 2023
- [483 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2019-12-20](https://www.globalkeysolutions.net/records/483/halo-pharmaceutical-inc-dba-cambrex-whippany/9b43103a-df0c-4d52-949f-0dabcb89d760) — source: FDA, date: December 20, 2019
- [FDA Inspection 1116333 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2019-12-20](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/0063451d-1d8e-48f6-afb9-c2589f60c73b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 20, 2019
- [FDA Inspection 1055544 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2018-05-30](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/00b592a9-1ab3-4d40-bb44-5de67256700c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2018
- [FDA Inspection 1027562 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-08-24](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/1e78476d-5351-47de-8c53-bd1f0aae370e) — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2017
- [483 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-03-20](https://www.globalkeysolutions.net/records/483/halo-pharmaceutical-inc-dba-cambrex-whippany/a15123c4-43cf-4ac7-b91b-ae2b1bc3e1de) — source: FDA, date: March 20, 2017
- [EIR - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-03-20](https://www.globalkeysolutions.net/records/eir/halo-pharmaceutical-inc-dba-cambrex-whippany/bea5e98a-7d52-49f7-92d3-f6bee3c9ba28) — source: FDA, date: March 20, 2017
- [FDA Inspection 1008344 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2017-03-20](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/9a730984-8411-4cbd-89ee-7407053ace5a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2017
- [FDA Inspection 974566 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - 2016-05-27](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-inc-dba-cambrex-whippany/2512a953-4d76-4795-8e6d-b4ce4de9793d) — classification: No Action Indicated (NAI), source: FDA, date: May 27, 2016

## Related Companies

- [New York Blood Center Enterprises](https://www.globalkeysolutions.net/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db)
- [Cipla Limited](https://www.globalkeysolutions.net/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Changzhou Pharmaceutical Factory](https://www.globalkeysolutions.net/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [IDT Australia Ltd.](https://www.globalkeysolutions.net/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Hospira Zagreb d.o.o.](https://www.globalkeysolutions.net/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1)
- [Minaris Regenerative Medicine, LLC](https://www.globalkeysolutions.net/companies/minaris-regenerative-medicine-llc/b5fdb186-e2e7-416c-b89e-66d15dbf5509)
- [Norbrook Laboratories Limited](https://www.globalkeysolutions.net/companies/norbrook-laboratories-limited/c9294f28-e127-43a0-b824-82a6f41fabfd)
- [Genentech, Inc.](https://www.globalkeysolutions.net/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [Patheon Pharmaceuticals Inc.](https://www.globalkeysolutions.net/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Shionogi Pharma Co., Ltd.](https://www.globalkeysolutions.net/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)

## Related Officers

- [Jogy George](https://www.globalkeysolutions.net/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [company_representative](https://www.globalkeysolutions.net/people/susan-saffar/30088266-5231-4727-b079-4ce60b7aaddf)
- [Director of Clinical Training](https://www.globalkeysolutions.net/people/helen-verdel/f6caf5a8-74f5-4833-bd00-5579b369f4f9)
- [Consumer Safety Officer/ORA/OMPTO/TOS](https://www.globalkeysolutions.net/people/niketa-patel/73efe456-da61-4345-8dec-7147b12b88d1)
- [investigator](https://www.globalkeysolutions.net/people/zhijin-chen/83b97abc-e295-4085-ac58-a4e7349620be)